Inhibrx Biosciences, Inc. INBX Lease Liability Payments - Remainder of Fiscal Year
Lease Liability Payments - Remainder of Fiscal Year at other companies
Other financials
Where this comes from
Reported directly by Inhibrx Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths.
The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s lease liability payments - remainder of fiscal year.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s lease liability payments - remainder of fiscal year?
- Inhibrx Biosciences, Inc. (INBX) reported lease liability payments - remainder of fiscal year of $2.94M in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s lease liability payments - remainder of fiscal year changed year-over-year?
- Inhibrx Biosciences, Inc.'s lease liability payments - remainder of fiscal year increased by 3.0% year-over-year, from $2.86M to $2.94M.
- What does lease liability payments - remainder of fiscal year mean?
- The contractual cash obligations for operating and finance leases due within the remaining months of the current fiscal year. This provides a short-term view of the company's fixed lease commitments. It is a critical component for assessing near-term liquidity and cash flow requirements.